Neuropathology, Genetics & Biomarker Core D Core Leader: John Q. Trojanowski, Core Co-Leader: Eddie Lee, Co-Investigator: Vivianna Van Deerlin Summary/Abstract: Neuropathology, Genetics & Biomarker Core D Nearly all neurodegenerative disorders are characterized by progressive accumulations of pathological deposits of disease protein aggregates within cells, blood vessels or in the neuropil and these deposits are the signature CNS lesions that define these disorders as exemplified by the senile plaques and neurofibrillary tangles required for the postmortem diagnosis of Alzheimer's disease (AD). However, Lewy bodies (LBs) and TDP-43 inclusions occur in >50% of AD patients, and mixed pathologies including hippocampal sclerosis and cerebrovascular disease are features of AD including prodromal stages of disease as in mild cognitive impairment (MCI) which shows AD and additional pathologies associated with other forms of dementia at autopsy. Further, 20-30% of patients with clinical AD have another neurodegenerative dementia other than AD and a similar percentage of patients diagnosed with clinical frontotemporal degeneration (FTD) have AD pathology while the remaining patients have autopsy confirmed frontotemporal lobar degeneration (FTLD) with tau, TDP-43 or FUS aggregates. Thus, a definite diagnosis of AD or related dementias is established only by postmortem neuropathology studies as performed in Core D, and an accurate neuropathology diagnosis is essential to elucidate mechanisms of AD and related dementias. Since multiple genetic factors contribute to the risk for AD and biomarkers signal disease onset/progression, DNA and biofluids are critical for clinical genetic and biomarker studies of AD. Hence, the University of Pennsylvania (Penn) AD Core Center (ADCC) collects, characterizes and banks CNS tissues, DNA and biofluids from well-characterized patients with MCI, AD and related disorders as well as normal controls followed in Clinical Core B. This approach enables a more comprehensive understanding of an individual patient's genetic risks, clinical manifestations, disease progression and neuropathology which are essential for conducting ADCC related research using Penn ADCC resources. Accordingly, Core D is the ?Neuropathology, Genetics and Biomarker Core? of this ADCC and it supports the mission of the Penn ADCC by working seamlessly with all Cores to accomplish its goals.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG010124-30
Application #
9962205
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
30
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Jedrziewski, M Kathryn; Meekins, Dara; Gorka, Samuel A et al. (2018) Feasibility of a Randomized Controlled Trial to Test the Impact of African Dance on Cognitive Function and Risk of Dementia: the REACT! Study. J Ment Health Clin Psychol 2:12-13
Chen-Plotkin, Alice S; Zetterberg, Henrik (2018) Updating Our Definitions of Parkinson's Disease for a Molecular Age. J Parkinsons Dis 8:S53-S57
Burke, Shanna L; Cadet, Tamara; Maddux, Marlaina (2018) Chronic Health Illnesses as Predictors of Mild Cognitive Impairment Among African American Older Adults. J Natl Med Assoc 110:314-325
Porta, Sílvia; Xu, Yan; Restrepo, Clark R et al. (2018) Patient-derived frontotemporal lobar degeneration brain extracts induce formation and spreading of TDP-43 pathology in vivo. Nat Commun 9:4220
Wisse, L E M; Das, S R; Davatzikos, C et al. (2018) Defining SNAP by cross-sectional and longitudinal definitions of neurodegeneration. Neuroimage Clin 18:407-412
Kamara, Dennis M; Gangishetti, Umesh; Gearing, Marla et al. (2018) Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease. J Alzheimers Dis 62:1815-1826
Hanfelt, John J; Peng, Limin; Goldstein, Felicia C et al. (2018) Latent classes of mild cognitive impairment are associated with clinical outcomes and neuropathology: Analysis of data from the National Alzheimer's Coordinating Center. Neurobiol Dis 117:62-71
Wang, Hua; Stewart, Tessandra; Toledo, Jon B et al. (2018) A Longitudinal Study of Total and Phosphorylated ?-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment. J Alzheimers Dis 61:1541-1553
Nativio, Raffaella; Donahue, Greg; Berson, Amit et al. (2018) Publisher Correction: Dysregulation of the epigenetic landscape of normal aging in Alzheimer's disease. Nat Neurosci 21:1018
Zhou, Zilu; Wang, Weixin; Wang, Li-San et al. (2018) Integrative DNA copy number detection and genotyping from sequencing and array-based platforms. Bioinformatics 34:2349-2355

Showing the most recent 10 out of 720 publications